REGN5668 / Regeneron  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
REGN5668 / Regeneron
R5668-ONC-1938, NCT04590326: A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018

Recruiting
1/2
612
Europe, US
REGN5668, Cemiplimab, REGN2810, Libtayo, REGN4018, Sarilumab
Regeneron Pharmaceuticals
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer
04/27
04/27

Download Options